Miriam Provost - Dec 23, 2021 Form 4 Insider Report for TransMedics Group, Inc. (TMDX)

Role: VP of US Regulatory & FDA Rel.
Signature: /s/ Stephen Gordon, Attorney-in-Fact
Stock symbol: TMDX
Transactions as of: Dec 23, 2021
Transactions value $: $2,846
Form type: 4
Date filed: 12/28/2021, 03:30 PM
Previous filing: Sep 17, 2021
Next filing: Feb 24, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TMDX	Common Stock	Options Exercise	$2.85K	+884	+10.33%	$3.22^*	9.44K	Dec 23, 2021	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TMDX	Stock Option (Right to Buy)	Options Exercise	$0	-884	-4.06%	$0.00	20.9K	Dec 23, 2021	Common Stock	884	$3.22	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The option vested 25% on the first anniversary of the vesting commencement date, February 20, 2018, and at a rate of 2.0833% each month thereafter until the option is fully vested on the fourth anniversary of the vesting date.